Newsfeeds Archive - Spark Newswire

2 minute read

Pfizer, Sanofi’s Respiratory Syncytial Virus Products Faces Insurance And Logistical Hurdles To Protect Infants

October 16, 12:16 PM

As the respiratory virus season kicks off, healthcare providers are racing against time to offer Pfizer Inc's (NYSE: PFE) vaccine, Abrysvo, to pregnant patients and Sanofi SA's (NASDAQ:

AZN

1 minute read

Unanimous Support for AstraZeneca and Sanofi’s Nirsevimab: Next Generation RSV Treatment on the Horizon

By Vandana Singh

June 9, 8:07 AM

The FDA's Antimicrobial Drugs Advisory Committee has voted unanimously 21 to 0 that AstraZeneca plc (NASDAQ: AZN) and Sanofi SA's (NASDAQ: SNY) nirsevimab has a favorable benefit-risk profile t

AZN

1 minute read

Apellis Pharma Flunks On Primary, Secondary Endpoints In Amyotrophic Lateral Sclerosis Study

By Vandana Singh

May 25, 1:14 PM

Apellis Pharmaceuticals Inc (NASDAQ:APLS) announced that the Phase 2 MERIDIAN study investigating systemic pegcetacoplan for amyotrophic lateral sclerosis (ALS)…

APLS

3 minute read

Benzinga’s ‘Stock Whisper’ Index: 5 Stocks Investors Are Secretly Monitoring But Not Talking About Yet

By Chris Katje

May 11, 5:43 PM

Investors are on the hunt for undervalued, underfollowed and emerging stocks and retail traders have countless methods at their disposal to uncover new information. For some, this may be overwhelming.

ABNB

1 minute read

European Swedish Orphan Biovitrum To Acquire CTI BioPharma For $1.7B

By Vandana Singh

May 10, 7:47 AM

Swedish Orphan Biovitrum AB (OTC: BIOVF) has agreed to acquire CTI BioPharma (NASDAQ: CTIC) for $9.10 per share of common stock in an all-cash transaction, representing an implied equity value of

BIOVF

1 minute read

Europe Approves AstraZeneca-Sanofi Partnered Antibody To Prevent RSV Infection In Infants

By Vandana Singh

November 4, 7:37 AM

The European Commission has approved AstraZeneca plc (NASDAQ:AZN) and Sanofi SA’s (NASDAQ:SNY) Beyfortus (nirsevimab) long-acting antibody to prevent respiratory syncytial virus (RSV) lower…

AZN

1 minute read

Sanofi’s Hemophilia Candidate Goes Under Priority FDA Review

By Vandana Singh

August 30, 6:46 AM

The FDA has accepted for priority review Sanofi SA’s (NASDAQ:SNY) marketing application for efanesoctocog alfa (BIVV001) for hemophilia A, a rare…

BIOVF

3 minute read

The Daily Biotech Pulse: Pfizer Inks Pact With Africa For COVID-19 Pills, Emergent Bio & Ridgeback To Increase Access To Ebola Treatment, ADC Therapeutics & Sobi In European Pact For Lymphoma Drug

By Vandana Singh

July 8, 8:19 AM

Here's a roundup of top developments in the biotech space over the last 24 hours:

ADCT

1 minute read

ADC Therapeutics, Sobi Ink European Licensing Pact For Lymphoma Drug

By Vandana Singh

July 8, 7:20 AM

ADC Therapeutics SA (NYSE:ADCT) has entered into an exclusive license agreement with Swedish Orphan Biovitrum AB (OTC:BIOVF) for the development and commercialization of…

ADCT